Health Care/Hospital
Empower tourism by Chinese medicine healthcare - The 4th Chongqing (Shizhu) Health and Wellness Conference opens in China
CHONGQING, China, Aug. 24, 2020 /PRNewswire/ -- August 22, the 4th China Chongqing (Shizhu) Health and Wellness Conference opened in Huangshui Town, Shizhu County. At the opening ceremony, 15 projects with a planned total investment of 41 billion Chinese yuan have been executed, all of which are ...
2020-08-24 12:50
3439
Singapore's Restalyst develops highly sensitive COVID-19 antibody test comparable to market leaders
SINGAPORE, Aug. 24, 2020 /PRNewswire/ -- Singapore biomedical firm Restalyst has developed a COVID-19 antibody test, COVID19N-REAAD™, which will be instrumental in establishing disease prevalence in populations and the exposure risk factors associated with infection. This will enable healthcare a...
2020-08-24 12:42
2328
The Korea Ginseng Association announces positive effects of Korean ginseng on respiratory infections
SEOUL, South Korea, Aug. 24, 2020 /PRNewswire/ -- As interests in
immune-boosting healthy functional foods continue to grow amidst of COVID-19's
worldwide spread, The Korea Ginseng Association has shared its nutritional
research for Korean Ginseng's effects on improving the immune system.
2020-08-24 11:00
4863
SDIC leads the investment of Xuanzhu Biopharmaceutical with RMB 800 million, promoting innovation and R&D
HONG KONG, Aug. 24, 2020 /PRNewswire/ -- Sihuan Pharmaceutical Holdings Group Ltd. (HKEX: 0460 "Sihuan Pharmaceutical" or the "Company", together with its subsidiaries, the "Group") is pleased to announce that Xuanzhu Biopharmaceutical, its innovative drug research and development platform, su...
2020-08-24 10:20
9884
US FDA Awards Orphan Drug Designation (ODD) To Paxalisib For Malignant Glioma, Including DIPG
SYDNEY, Aug. 24, 2020 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce that the United States Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to Kazia's paxalisib (formerl...
2020-08-24 09:14
6344
Harbour BioMed Presented Its Newly Discovered BCMA x CD3 Bispecific Antibody at Cell Engager Summit 2020
CAMBRIDGE, Mass., ROTTERDAM, Netherlands, and SUZHOU, China, Aug. 21, 2020 /PRNewswire/ -- Harbour BioMed (HBM), a global, clinical-stage, innovative biopharmaceutical company, presented its newly discovered Bispecific Antibody - BCMA x CD3 (HBM7020) at the Cell engager Summit. HBM7020 was develo...
2020-08-21 21:31
6938
Zhongchao Inc. Offers Advanced Workshops in Partnership with European Wound Management Association (EWMA)
SHANGHAI, Aug. 21, 2020 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a healthcare services company offering patient management, online healthcare information, professional training and educational services, today announced that it continues to partner with Europe...
2020-08-21 18:59
6266
Ping An Healthcare and Technology Company Limited Announces 2020 Interim Report
SHANGHAI, Aug. 21, 2020 /PRNewswire/ -- Ping An Good Doctor ("Ping An Good Doctor", 01833.HK), the world's leading online healthcare platform, announced the revenue ofRMB 2.747 billion for the first half of this year, according to the company's latest financial report. Ping An Good Doctor perf...
2020-08-21 16:30
16303
KPMG and DXY launch book titled "Human: Solving the Global Workforce Crisis in Healthcare"
HONG KONG, Aug. 21, 2020 /PRNewswire/ -- KPMG and Dingxiangyuan (DXY), an online networking site for healthcare professionals, jointly hosted a virtual conference for the launch of the Chinese version of the book,Human: Solving the Global Workforce Crisis in Healthcare. Attendees included Mark ...
2020-08-21 10:46
3561
Cipla and Stempeutics collaborate for launch of Stempeucel®, first 'Made in India' Cell Therapy to treat Critical Limb Ischemia (CLI)
MUMBAI, India, Aug. 21, 2020 /PRNewswire/ -- Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) referred to as "Cipla" today announced that its partner Stempeutics Research Pvt. Ltd has received regulatory approval by the Drug Controller General ofIndia (DCGI) for the launch of Stempeucel® in India. The...
2020-08-21 06:00
9212
Ping An Healthcare and Technology Company Limited reports revenue of RMB 2.747 billion for H1 2020
SHANGHAI, Aug. 21, 2020 /PRNewswire/ -- Ping An Good Doctor ("Ping An Good
Doctor", 01833.HK), the world's leading online healthcare platform, announced
the revenue ofRMB 2.747 billion for the first half of this year, according to
the company's latest financial report.
2020-08-21 01:04
14331
Clarivate Launches Coronavirus, Virology, and Infectious Disease (CVID) Data Lake to Accelerate Research, Preparedness and Response to Future Pandemics
Broad and deep intelligence -- harmonized and accessed via one single, secure source -- powers unique insights not possible via disconnected, siloed datasets LONDON, Aug. 20, 2020 /PRNewswire/ -- Clarivate Plc (NYSE: CCC), a global leader in providing trusted information and insights to accelerat...
2020-08-20 22:03
9483
South Korea's KT Develops AI-Based COVID-19 Research
SEOUL, South Korea, Aug. 20, 2020 /PRNewswire/ -- KT Corp. (KRX: 030200; NYSE: KT),South Korea's largest telecommunications company, is developing a COVID-19 infection risk assessment model, using its artificial intelligence (AI) and Big Data-based digital contact tracing technology, adding to gl...
2020-08-20 21:00
8439
Hong Kong's Hang Fook Elderly Home Adopts iBonus(R) Digital Prevention System Aimed at Helping Guard Against COVID-19
HONG KONG, Aug. 20, 2020 /PRNewswire/ -- One of the key reasons that COVID-19 has caused a great concern is its long incubation period. Most experts agree that for up to 14 days many affected patients have no obvious symptoms. Since nobody knows where these people have been or who they have been ...
2020-08-20 20:35
3329
Ascletis Completed Bridging Study of ASC18, a One-pill, Once-a-day Complete HCV Oral Regimen
HANGZHOU and SHAOXING, China, Aug. 20, 2020 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX code: 1672) announces today that it completed bridging study of ASC18, first one-pill, once-a-day fixed dose combination (FDC) as the complete hepatitis C treatment developed by a Chinese biotech. ASC18 FDC co...
2020-08-20 20:00
3695
Sihuan Pharmaceutical Introduced Investors for Capital Increase to Accelerate Solid-liquid Double Chamber Infusion Soft Bag Industry
HONG KONG, Aug. 20, 2020 /PRNewswire/ -- Sihuan Pharmaceutical Holdings Group Ltd. (HKEX: 0460 "Sihuan Pharmaceutical" or the "Company", together with its subsidiaries, the "Group") is pleased to announce that Beijing Ruiye Drugs Manufacture Co., Ltd. ("Beijing Ruiye"), an associate of the Grou...
2020-08-20 19:39
13706
Low-Cost Nafamostat Blocks SARS-CoV-2 Infection in Human Lung Cells, Preclinical Study Finds
SAN DIEGO, Aug. 20, 2020 /PRNewswire/ -- A preclinical study testing the low-cost generic drug nafamostat in human cells shows it can help block SARS-CoV-2 infection, raising excitement around Covistat's work to develop prophylactic and therapeutic COVID-19 treatments. Biopharmaceutical company ...
2020-08-20 19:00
2658
CARsgen Therapeutics Receives IND Clearance from the NMPA for CT041 CLDN18.2-CAR-T Cells
SHANGHAI, Aug. 20, 2020 /PRNewswire/ -- CARsgen Therapeutics Co., Ltd., a clinical-stage biopharmaceutical company, today announced that the National Medical Products Administration (NMPA) has cleared its Investigational New Drug (IND) application for the first-in-class drug candidate CT041, auto...
2020-08-20 18:32
3615
LumiraDx Receives FDA Emergency Use Authorization for Point of Care COVID-19 Antigen Test
LONDON, Aug. 20, 2020 /PRNewswire/ -- LumiraDx, the next-generation point of care diagnostic company, announced today that it hasreceived Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for the LumiraDx SARS-CoV-2 antigen test, which will help meet the global ch...
2020-08-20 18:00
3784
111, Inc. Announces Second Quarter 2020 Unaudited Financial Results
SHANGHAI, Aug. 20, 2020 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a company dedicated to digitally connecting patients with drugs and healthcare services inChina, today announced its unaudited financial results for the second quarter endedJune 30, 2020. Second Quarter 2020...
2020-08-20 16:35
11353
Week's Top Stories
Most Reposted
Protiviti Transforms Cyber Risk Consulting with CYFIRMA's Advanced Intelligence-Led Cybersecurity
[Picked up by 324 media titles]
2024-04-15 09:00Sephora appoints Xia Ding as Managing Director of Sephora Greater China
[Picked up by 302 media titles]
2024-04-15 17:33
AI-DOL: Revolutionising the Future of Entertainment with AI-Powered Virtual Idols
[Picked up by 295 media titles]
2024-04-12 15:14
LEGOLAND® School Challenge 2024 Expands Across Asia and Opens for Registration on April 15th
[Picked up by 276 media titles]
2024-04-11 11:00
Allianz Partners Introduces Instant Online Chat for HCF Travel Insurance Customers
[Picked up by 275 media titles]
2024-04-15 08:00
Most Read
LEGOLAND® School Challenge 2024 Expands Across Asia and Opens for Registration on April 15th
2024-04-11 11:00
6683
AI-DOL: Revolutionising the Future of Entertainment with AI-Powered Virtual Idols
2024-04-12 15:14
6394
XCMG Machinery Launches Premium G2 Crane Brand
2024-04-12 14:39
6329
